737765-57-0 Usage
Uses
Used in Pharmaceutical Industry:
Cyclopentanol, 1-(trifluoromethyl)(9CI) serves as an important intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key building block for developing new drugs with specific therapeutic properties.
Used in Agricultural Chemicals:
In the agricultural sector, Cyclopentanol, 1-(trifluoromethyl)(9CI) is utilized in the production of agrochemicals, such as pesticides and herbicides. Its chemical properties make it suitable for creating effective and targeted solutions for crop protection.
Used as a Solvent in Organic Synthesis:
Cyclopentanol, 1-(trifluoromethyl)(9CI) is employed as a solvent in organic synthesis processes. Its ability to dissolve a wide range of compounds and its compatibility with various reaction conditions make it a valuable asset in the synthesis of complex organic molecules.
Used in Synthesis of Other Organic Compounds:
As a building block, Cyclopentanol, 1-(trifluoromethyl)(9CI) is used in the synthesis of other organic compounds, contributing to the development of new materials and chemicals for various industries. Its unique structure and properties enable the creation of innovative and specialized products.
Check Digit Verification of cas no
The CAS Registry Mumber 737765-57-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,7,7,6 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 737765-57:
(8*7)+(7*3)+(6*7)+(5*7)+(4*6)+(3*5)+(2*5)+(1*7)=210
210 % 10 = 0
So 737765-57-0 is a valid CAS Registry Number.
737765-57-0Relevant articles and documents
TRPA1 ANTAGONISTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH PAIN AND INFLAMMATION
-
Page/Page column 27, (2021/11/26)
The present invention is directed to compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions comprising said compounds,
MODULATORS OF GPR119 AND THE TREATMENT OF DISORDERS RELATED THERETO
-
Page/Page column 95; 96, (2014/05/24)
The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof, Formula (I), that are useful as single pharmaceutical agents or in combination with one or more additional pharmaceutical agen
